American Capital Management Inc. Takes Position in Globus Medical, Inc. $GMED

American Capital Management Inc. acquired a new stake in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 653,072 shares of the medical device company's stock, valued at approximately $51,599,000. Globus Medical comprises 2.3% of American Capital Management Inc.'s portfolio, making the stock its 16th largest holding. American Capital Management Inc. owned approximately 0.49% of Globus Medical as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in GMED. Northwestern Mutual Wealth Management Co. lifted its position in Globus Medical by 71,618.6% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 716,469 shares of the medical device company's stock worth $62,555,000 after acquiring an additional 715,470 shares during the last quarter. WCM Investment Management LLC bought a new stake in Globus Medical during the first quarter valued at about $16,965,000. SG Americas Securities LLC grew its position in shares of Globus Medical by 241.1% in the first quarter. SG Americas Securities LLC now owns 340,452 shares of the medical device company's stock valued at $29,333,000 after purchasing an additional 240,642 shares during the last quarter. Artemis Investment Management LLP grew its position in shares of Globus Medical by 43.7% in the fourth quarter. Artemis Investment Management LLP now owns 738,595 shares of the medical device company's stock valued at $64,487,000 after purchasing an additional 224,587 shares during the last quarter. Finally, Hyperion Capital Advisors LP bought a new position in shares of Globus Medical in the fourth quarter worth about $12,822,000. Hedge funds and other institutional investors own 95.16% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Piper Sandler cut their price objective on shares of Globus Medical from $115.00 to $100.00 and set an "overweight" rating for the company in a research report on Monday, June 15th. Wells Fargo & Company decreased their target price on Globus Medical from $103.00 to $99.00 and set an "overweight" rating on the stock in a research report on Friday, August 7th. Zacks Research upgraded Globus Medical from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 10th. Needham & Company LLC upped their price target on Globus Medical from $114.00 to $117.00 and gave the company a "buy" rating in a report on Friday, May 8th. Finally, Truist Financial reduced their price objective on Globus Medical from $115.00 to $100.00 and set a "buy" rating for the company in a research report on Thursday, July 16th. Three research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $101.77.

Globus Medical Stock Up 0.3%

Shares of NYSE:GMED opened at $83.18 on Thursday. The firm has a market cap of $11.17 billion, a P/E ratio of 21.27, a P/E/G ratio of 1.33 and a beta of 0.95. Globus Medical, Inc. has a 12 month low of $54.15 and a 12 month high of $101.40. The company's 50-day moving average price is $80.98 and its two-hundred day moving average price is $84.66.

Globus Medical (NYSE:GMED - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The medical device company reported $1.34 EPS for the quarter, beating analysts' consensus estimates of $1.10 by $0.24. Globus Medical had a return on equity of 14.57% and a net margin of 17.02%.The firm had revenue of $789.61 million for the quarter, compared to analyst estimates of $782.88 million. During the same period last year, the company earned $0.86 EPS. The business's quarterly revenue was up 5.9% compared to the same quarter last year. Globus Medical has set its FY 2026 guidance at 4.950-5.050 EPS. As a group, equities analysts predict that Globus Medical, Inc. will post 4.99 earnings per share for the current fiscal year.

Insider Transactions at Globus Medical

In related news, Director Stephen T. Zarrilli sold 25,000 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $87.04, for a total value of $2,176,000.00. Following the completion of the transaction, the director directly owned 25,000 shares in the company, valued at approximately $2,176,000. The trade was a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director David D. Davidar sold 25,000 shares of the stock in a transaction on Friday, June 5th. The stock was sold at an average price of $80.76, for a total transaction of $2,019,000.00. Following the sale, the director directly owned 510,175 shares of the company's stock, valued at $41,201,733. This represents a 4.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 18.38% of the stock is currently owned by insiders.

Globus Medical Profile

Globus Medical, Inc NYSE: GMED is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source